NSECertificate under SEBI (Depositories and Participants) Regulations, 20188 Jul 2026 · 8 Jul 2026, 11:00 am
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Alembic Pharmaceuticals Limited · APLLTD
✦ AI Summary
Alembic Pharmaceuticals Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities for the quarter ended June 30, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Alembic Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Attachments (1)
📄pdf
Download →
APLLTD_08072026110019_Certificate_74_5__SE_Intimation.pdf
View document text
Date: gth July, 2026
To, To,
The Manager, The Manager,
BSE Limited National Stock Exchange of India Ltd.
P. J. Towers, Dalal Street, 'Exchange Plaza', Bandra Kurla Complex,
Fort, Mumbai - 400 001 Bandra (E), Mumbai - 400 051
BSE Scrip Code: 533573 NSE Symbol: APLL TD
Dear Sir/Madam,
Sub: Certificate under Regulation 74(5) of the SEBI (Depositories and
Participants) Regulations, 2018 for the quarter ended 301 June, 2026
With reference to the captioned matter, please find enclosed herewith a Certificate
under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for
the quarter ended 3Q1 June, 2026 received from Mis. MUFG lntime India Private
Limited (Formerly known as M/s. Link lntime India Private Limited), Registrar and
Share Transfer Agent of our Company.
We request you to kindly take the same on record.
Thanking you,
Yours faithfully,
For Alembic Pharmaceuticals Limited
~aSaraf
Company Secretary
Encl.: Na.
ALEMBIC PHARMACEUTICALS LIMITED
REGO. OFFICE: ALEMBIC ROAD, VADODARA- 390 003. •TEL: (0265) 2280550, 2280880
Website: www.alembicpharmaceuticals.com •E-mail: alembic@alembic.co.in • CIN: L24230GJ2010PLC061123
MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
CIN: U67190MH1999PTC118368
Registered Address:
C-101, Embassy 247, L.B.S. Marg,
Vikhroli (West), Mumbai - 400083.
Tel: +91 22 4918 6000
www.in.mpms.mufg.com
Date : 01-07-2026
The Compliance Officer/ Company Secretary
ALEMBIC PHARMACEUTICALS LIMITED
P.O.BOX 1, MONALISA APT 48
NUTAN BHARAT SOC,
ALKAPURI,
VADODARA
VADODARA
PINCODE : 390005
Sub : Confirmation Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and
Participants) Regulations, 2018.
Dear Sir/Madam,
In reference to the above captioned regulation, we hereby confirm that the securities received from the depository participants for
dematerialisation during the quarter ended 30th June 2026, were confirmed (accepted/rejected) to the depositories by us and that
securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued securities are listed.
We hereby also confirm that the security certificates received for dematerialisation have been confirmed/rejected and the security
certificates received were mutilated and cancelled after due verification by the depository participant and the name of the
depositories have been substituted in the register of members as the registered owner within the prescribed timelines. We request
you to kindly take note of the above in your records.
Thanking you,
Yours faithfully,
For MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
Ashok Shetty
Sr. Vice President-Corporate Registry
MUFG Intime India Private Limited
A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services